MARIJEAN BUHSE: Open Payments
NPI 1720091556 · EAST MEADOW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,436 in 37 payments from 9 companies in 2025. Trend: 2023 $9,157 · 2024 $13,885 · 2025 $8,436
Speaker / faculty: $5,292Food & beverage: $1,623Consulting: $1,471Travel & lodging: $50
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 21 | $6,327 |
| Merck KGaA | 1 | $880 |
| EMD Serono, Inc. | 4 | $422 |
| Amgen Inc. | 4 | $174 |
| ARGENX US, INC. | 2 | $151 |
| E.R. Squibb & Sons, L.L.C. | 2 | $146 |
| PFIZER INC. | 1 | $125 |
| Genentech USA, Inc. | 1 | $106 |
| Novartis Pharmaceuticals Corporation | 1 | $106 |
Products named: VUMERITY, TYSABRI, ZEPOSIA, ZAVZPRET, VYVGART, Mavenclad, Ocrevus, KESIMPTA.
Industry payments across NY — which companies pay providers there.
